達維塔保健 DVA 深 滬
已收盤 02-06 16:00:00 美东时间
140.83
-8.390
-5.62%
華盛通- 最 高151.42
- 今 開149.00
- 成交量 225.53万股
- 最 低 139.54
- 昨 收 149.22
- 總市值 94.14亿
- 52周最高 158.21
- 市盈率 靜 14.31
- 換手率 0.00%
- 52周最低 101.00
- 委 比 0.00%
- 總股本 6684.90万
- 歷史最高 179.60
- 量 比 0.83
- 振 幅 7.96%
- 歷史最低 43.40
- 每 手 1
- 風險率 14.27%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 泰瑞达、Lumentum、哈贝尔、Enphase能源、西部数据获多家机构上调目标价；PayPal 、恩智浦、墨式烧烤遭多家机构下调目标价
今日重点评级关注：韦德布什：维持Replimune Group"跑赢大市"评级，目标价从18美元升至19美元；巴克莱：维持CytomX Therapeutics"超配"评级，目标价从8美元升至10美元
02-05 11:28
美股牛股 | 达维塔保健绩后飙升逾21%！Q4业绩胜市场预期；稀土概念股Critical Metals大涨超20%
达维塔保健绩后飙升逾21%！Q4业绩胜市场预期；稀土概念股CRML大涨超20%，美内政部长称将宣布关键矿产贸易协议；金矿股HYMC隔夜涨超19%，现货黄金重上5000美元关口>>
02-04 15:15
美股大行评级 | 潜在涨幅213.87%！Wave Life Sciences获Canaccord Genuity升目标价至43美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences Ltd."买入"评级，目标价从40美元升至43美元；花旗：维持Palantir Technologies"买入"评级，目标价从235美元升至260美元
02-04 12:15
DaVita Earnings Call Signals Cautious Optimism
Davita Healthcare (($DVA)) has held its Q4 earnings call. Read on for the main ...
02-04 08:25
DaVita Stock Rallies On Profit Beat, Confident 2026 View
DaVita stock surged after the kidney care provider beat earnings estimates and issued strong 2026 guidance, signaling stable treatment volumes, higher reimbursement rates, and an improving income outlook.
02-04 01:25
Barclays Maintains Equal-Weight on DaVita, Raises Price Target to $158
Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price target from $143 to $158.
02-03 21:30
BUZZ-U.S. STOCKS ON THE MOVE- Merck & Co, McDonald's, FedEx
BUZZ-U.S. STOCKS ON THE MOVE- Merck & Co, McDonald's, FedEx Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Futures tracking the S&P 500 and the Nasdaq edged higher on Tuesday, stead
02-03 20:18
BUZZ-DaVita rises on upbeat annual profit forecast
BUZZ-DaVita rises on upbeat annual profit forecast ** Dialysis firm DaVita's DVA.N shares rise 10.6% to $121.05 premarket after co forecasts annual profit above estimates ** Co expects 2026 adj. EPS to be between $13.60 and $15 vs analysts' average estimate of $12.65 - LSEG data ** DVA attributes up
02-03 19:48
Berkshire Hathaway Reports Sale of DaVita Inc. Common Shares
Berkshire Hathaway Reports Sale of DaVita Inc. Common Shares Berkshire Hathaway Inc. has reported the disposal of common shares of DaVita Inc. The filing lists Berkshire Hathaway Inc. as a beneficial owner, along with other reporting beneficial owners. The full filing can be accessed through the lin
02-03 06:30
